Smilegate\'s deep expertise in Asian markets coupled with Dan Houser and the Absurd Ventures team\'s creative vision and blockbuster AAA game experience aims to create vast and sustainable global busi
Researchers from Children\'s Hospital of Philadelphia (CHOP) seek to expand treatment access for patients
BTL,a leader in medical innovation,is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next
In a Pitch Cycle That Saw 50% Churn Rate,OMG Is #1 for Retention,Holding on to 85% of Its Billings in Play
VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat
AUSTIN,Texas,Dec. 4,2024-- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David\'s Medical Center recently became the first in the nation to usean all-in-one high-density
